Human oxidized LDL receptor
US5945308A · kind A · utility
17Cited by
0References
7Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Apr 3, 1998 |
| Grant date | Aug 31, 1999 |
| Priority date | — |
| Expiry date | Apr 3, 2018 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC12N2799/021
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The invention provides a human oxidized LDL receptor (HOLR) and polynucleotides which identify and encode HOLR. The invention also provides expression vectors, host cells, antibodies, agonists, and antagonists. The invention also provides methods for diagnosing, treating, or preventing disorders associated with expression of HOLR.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.